These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 6768396)

  • 21. The covalent structure of apolipoprotein A-I from canine high density lipoproteins.
    Chung H; Randolph A; Reardon I; Heinrikson RL
    J Biol Chem; 1982 Mar; 257(6):2961-7. PubMed ID: 6801039
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The measurement of apolipoprotein A-I and A-II levels of human plasma high density lipoprotein (HDL) by single radial immunodiffusion (SRID) method].
    Miyahara T; Murai A; Kameyama M
    Nihon Ronen Igakkai Zasshi; 1982 Nov; 19(6):583-7. PubMed ID: 6820093
    [No Abstract]   [Full Text] [Related]  

  • 23. Apoprotein (E--A-II) complex of human plasma lipoproteins. I. Characterization of this mixed disulfide and its identification in a high density lipoprotein subfraction.
    Weisgraber KH; Mahley RW
    J Biol Chem; 1978 Sep; 253(17):6281-8. PubMed ID: 210174
    [No Abstract]   [Full Text] [Related]  

  • 24. Apolipoprotein-specific populations in high density lipoproteins of human cord blood.
    Nichols AV; Blanche PJ; Genzel-Boroviczeny O; Forte TM; Gong EL
    Biochim Biophys Acta; 1991 Oct; 1085(3):306-4. PubMed ID: 1911864
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human apolipoprotein A-II determines plasma triglycerides by regulating lipoprotein lipase activity and high-density lipoprotein proteome.
    Julve J; Escolà-Gil JC; Rotllan N; Fiévet C; Vallez E; de la Torre C; Ribas V; Sloan JH; Blanco-Vaca F
    Arterioscler Thromb Vasc Biol; 2010 Feb; 30(2):232-8. PubMed ID: 19910634
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of the apolipoproteins of rat plasma lipoproteins.
    Swaney JB; Braithwaite F; Eder HA
    Biochemistry; 1977 Jan; 16(2):271-8. PubMed ID: 65178
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of cholesterol concentrations in low-density lipoprotein, high-density lipoprotein, and high-density lipoprotein subfractions, and of apolipoproteins AI and AII, with coronary stenosis and left ventricular function.
    Kempen HJ; van Gent CM; Buytenhek R; Buis B
    J Lab Clin Med; 1987 Jan; 109(1):19-26. PubMed ID: 3098880
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Selective proteolytic digestion as a method for the modification of human HDL3 structure.
    Swaney JB
    J Lipid Res; 1983 Mar; 24(3):245-52. PubMed ID: 6405003
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tangier disease: a structural defect in apolipoprotein A-I (apoA-I Tangier).
    Kay LL; Ronan R; Schaefer EJ; Brewer HB
    Proc Natl Acad Sci U S A; 1982 Apr; 79(8):2485-9. PubMed ID: 6806810
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Coupling of photoactivatable glycolipid probes to apolipoproteins A-I and A-II in human high density lipoproteins 2 and 3.
    Berkhout TA; Groot PH; van Belzen R; Wirtz KW
    J Lipid Res; 1985 Aug; 26(8):964-9. PubMed ID: 3930643
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A simplified and efficient procedure for the purification of apolipoprotein AI from human serum high-density lipoprotein-3 by preparative isoelectric focussing on polyacrylamide gel beads.
    Forgez P; Chapman MJ
    J Biochem Biophys Methods; 1982 Sep; 6(4):283-96. PubMed ID: 6183309
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Apolipoproteins of human plasma high density lipoproteins. Biology, biochemistry and clinical significance.
    Scanu AM; Edelstein C; Gordon JI
    Clin Physiol Biochem; 1984; 2(2-3):111-22. PubMed ID: 6435927
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Studies on the interaction between apolipoprotein A-II-enriched HDL3 and cultured bovine aortic endothelial (BAE) cells.
    Vadiveloo PK; Fidge NH
    Biochim Biophys Acta; 1990 Jul; 1045(2):135-41. PubMed ID: 2116175
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of the lytic action of cell-bound terminal complement components by human high density lipoproteins and apoproteins.
    Rosenfeld SI; Packman CH; Leddy JP
    J Clin Invest; 1983 Apr; 71(4):795-808. PubMed ID: 6403580
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The measurement of apolipoprotein A-I and A-II levels in men and women by immunoassay.
    Cheung MC; Albers JJ
    J Clin Invest; 1977 Jul; 60(1):43-50. PubMed ID: 194921
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Isolation and characterization of a human serum cholesteryl ester transfer protein.
    Chajek T; Fielding CJ
    Proc Natl Acad Sci U S A; 1978 Jul; 75(7):3445-9. PubMed ID: 210460
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Trauma, high density lipoproteins, and serum amyloid protein A.
    Eriksen N; Benditt EP
    Clin Chim Acta; 1984 Jul; 140(2):139-49. PubMed ID: 6432369
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The distribution and partial characterization of the serum apolipoproteins in the guinea pig.
    Chapman MJ; Mills GL; Ledford JH
    Biochem J; 1975 Aug; 149(2):423-36. PubMed ID: 170915
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Purification and characterization of a senile amyloid-related antigenic substance (apoSASSAM) from mouse serum. apoSASSAM is an apoA-II apolipoprotein of mouse high density lipoproteins.
    Higuchi K; Yonezu T; Kogishi K; Matsumura A; Takeshita S; Higuchi K; Kohno A; Matsushita M; Hosokawa M; Takeda T
    J Biol Chem; 1986 Sep; 261(27):12834-40. PubMed ID: 3091606
    [TBL] [Abstract][Full Text] [Related]  

  • 40. On the mechanism of the displacement of apolipoprotein A-I by apolipoprotein A-II from the high density lipoprotein surface. Effect of concentration and molecular forms of apolipoprotein A-II.
    Edelstein C; Halari M; Scanu AM
    J Biol Chem; 1982 Jun; 257(12):7189-95. PubMed ID: 6806266
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.